Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Hirsh, V., et al. - The optimal combination of concomitant radiotherapy (RT) and chemotherapy in stage III unresectable non-small cell lung cancer (NSCLC) remains unclear. The role of induction chemotherapy with carboplatin/gemcitabine regimen has not been established in stage III NSCLC...Conclusion: This regimen appears to be effective and was well tolerated. Further studies using this approach are warranted in patients with stage III NSCLC


Today in Hematology/Oncology...keeping you current

Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09

Update on oral lichen planus
Expert Review of Dermatology, 10/14/09

Oestrogen plus progestin and lung cancer in postmenopausal women (Womens Health Initiative trial): a post-hoc analysis of a randomised controlled trial
The Lancet, 10/12/09

Today in Radiology/Diagnostics...keeping you current

Allergic rhinitis with negative skin tests: Does it exist
Allergy and Asthma Proceedings, 10/13/09

Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09

Hemoglobin A1C and diabetes diagnosis: The Rancho Bernardo Study
Diabetes Care, 10/28/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address